<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">        <PMID Version="1">30073604</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>23</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>23</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1179-1969</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>35</Volume>                    <Issue>8</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>08</Month>                    </PubDate>                </JournalIssue>                <Title>Drugs &amp; aging</Title>                <ISOAbbreviation>Drugs Aging</ISOAbbreviation>            </Journal>            <ArticleTitle>The Management of Menopausal Symptoms in Women Following Breast Cancer: An Overview.</ArticleTitle>            <Pagination>                <MedlinePgn>699-705</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40266-018-0574-y</ELocationID>            <Abstract>                <AbstractText>The improved detection and successful treatment of breast cancer, resulting in better survival rates, has led to an increasing number of women living with the effects of treatment modalities and their long-term consequences. Menopausal symptoms following breast cancer can occur at an earlier age, be more severe and significantly influence a woman's overall wellbeing, in particular, sexual function, quality of life and adherence to treatment. There is a dearth of good quality evidence on the safest and most effective treatment options available for these women, and this article aims to summarize the current available treatments. Pertinent to these women is general advice, such as avoidance of triggers, and lifestyle modifications. Following which, non-pharmacological interventions, including cognitive behavior therapy (CBT), hypnosis, acupuncture, stellate ganglion nerve block and complementary agents, are discussed. Pharmacological therapies and their safety profile in these high-risk women are then examined; namely, menopausal hormone therapy, progestogens, antidepressants (selective serotonin reuptake inhibitors and selective noradrenaline reuptake inhibitors), gabapentin, clonidine and intra-vaginal dehydroepiandrosterone (DHEA). Finally, neurokinin 3 receptor antagonists, promising new agents for the treatment of troublesome menopausal vasomotor symptoms, are discussed.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Phua</LastName>                    <ForeName>Cheryl</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Baber</LastName>                    <ForeName>Rodney</ForeName>                    <Initials>R</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7043-5099</Identifier>                    <AffiliationInfo>                        <Affiliation>Obstetrics and Gynaecology, Sydney Medical School North, Royal North Shore Hospital, The University of Sydney, Sydney, Australia. rodney.baber@sydney.edu.au.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>New Zealand</Country>            <MedlineTA>Drugs Aging</MedlineTA>            <NlmUniqueID>9102074</NlmUniqueID>            <ISSNLinking>1170-229X</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000588">Amines</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D003509">Cyclohexanecarboxylic Acids</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>56-12-2</RegistryNumber>                <NameOfSubstance UI="D005680">gamma-Aminobutyric Acid</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>6CW7F3G59X</RegistryNumber>                <NameOfSubstance UI="C040029">gabapentin</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2008 Jun;9(6):523-32</RefSource>                <PMID Version="1">18485819</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Oncol. 2018 Aug 1;4(8):1059-1065</RefSource>                <PMID Version="1">29710224</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Maturitas. 2003 May 30;45(1):29-38</RefSource>                <PMID Version="1">12753941</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cochrane Database Syst Rev. 2013 Dec 10;(12):CD001395</RefSource>                <PMID Version="1">24323914</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2016 Feb 2;164(3):146-54</RefSource>                <PMID Version="1">26784863</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2011 Oct 10;29(29):3862-8</RefSource>                <PMID Version="1">21911720</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2012 Mar 7;104(5):386-405</RefSource>                <PMID Version="1">22271773</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Climacteric. 2013 Feb;16(1):41-7</RefSource>                <PMID Version="1">23017097</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2008 Jan;107(2):167-80</RefSource>                <PMID Version="1">17876703</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cochrane Database Syst Rev. 2014 Nov 28;(11):CD006108</RefSource>                <PMID Version="1">25431132</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2017 May 6;389(10081):1809-1820</RefSource>                <PMID Version="1">28385352</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2008 Nov 1;26(31):5022-6</RefSource>                <PMID Version="1">18809612</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 Jan;67(1):7-30</RefSource>                <PMID Version="1">28055103</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2008 Oct 1;100(19):1361-7</RefSource>                <PMID Version="1">18812548</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Maturitas. 1981 Aug;3(2):167-72</RefSource>                <PMID Version="1">7289887</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Menopause. 2004 Sep-Oct;11(5):519-30</RefSource>                <PMID Version="1">15356404</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2005 Sep;6(9):687-95</RefSource>                <PMID Version="1">16129369</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Endocrinol (Copenh). 1991;125 Suppl 1:7-12</RefSource>                <PMID Version="1">1839345</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pain Symptom Manage. 2002 Jun;23(6):501-9</RefSource>                <PMID Version="1">12067774</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Maturitas. 2011 Dec;70(4):343-8</RefSource>                <PMID Version="1">22014722</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Endocrinol Metab. 2010 Jul;95(7 Suppl 1):s1-s66</RefSource>                <PMID Version="1">20566620</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Endocrinol Metab. 2015 Nov;100(11):3975-4011</RefSource>                <PMID Version="1">26444994</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Menopause. 2014 Mar;21(3):267-74</RefSource>                <PMID Version="1">23860358</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2017 Jan;52:82-90</RefSource>                <PMID Version="1">27960127</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Maturitas. 2010 Dec;67(4):296-308</RefSource>                <PMID Version="1">20880642</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Menopause. 2018 Jan;25(1):11-20</RefSource>                <PMID Version="1">28816933</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Menopause. 2005 Jul-Aug;12(4):436-43</RefSource>                <PMID Version="1">16037759</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Menopause. 2008 Jul-Aug;15(4 Pt 1):655-60</RefSource>                <PMID Version="1">18427355</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Climacteric. 2006 Feb;9(1):49-58</RefSource>                <PMID Version="1">16428125</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Climacteric. 2016 Apr;19(2):109-50</RefSource>                <PMID Version="1">26872610</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Menopause. 2016 Jul;23(7):708-18</RefSource>                <PMID Version="1">27163520</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2017 Nov 23;359:j5101</RefSource>                <PMID Version="1">29170264</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pain Symptom Manage. 2002 Dec;24(6):603-7</RefSource>                <PMID Version="1">12551811</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Steroids. 2015 Jul;99(Pt A):32-8</RefSource>                <PMID Version="1">25163006</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Endocrinol Metab. 2011 Feb;96(2):308-19</RefSource>                <PMID Version="1">21147884</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Menopause. 2014 Aug;21(8):807-14</RefSource>                <PMID Version="1">24496086</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2004 Feb 7;363(9407):453-5</RefSource>                <PMID Version="1">14962527</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2005 Apr 6;97(7):533-5</RefSource>                <PMID Version="1">15812079</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cochrane Database Syst Rev. 2013 Jul 30;(7):CD007410</RefSource>                <PMID Version="1">23897589</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Obstet Gynecol. 1980 Sep 1;138(1):99-104</RefSource>                <PMID Version="1">7416212</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cochrane Database Syst Rev. 2010 Sep 08;(9):CD004923</RefSource>                <PMID Version="1">20824841</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychosom Med. 2015 Feb-Mar;77(2):167-75</RefSource>                <PMID Version="1">25647753</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2012 Jun;23(6):1449-54</RefSource>                <PMID Version="1">22039079</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Menopause. 2014 Oct;21(10):1075-81</RefSource>                <PMID Version="1">24618765</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2008 Oct;19(10):1669-80</RefSource>                <PMID Version="1">18522932</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2009 Feb;10(2):135-46</RefSource>                <PMID Version="1">19167925</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Neuroendocrinol. 2013 Aug;34(3):211-27</RefSource>                <PMID Version="1">23872331</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Fertil Steril. 2008 Jul;90(1):17-22</RefSource>                <PMID Version="1">17706209</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Maturitas. 2003 Dec 10;46 Suppl 1:S59-69</RefSource>                <PMID Version="1">14670647</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Nurs. 2005 Feb;14(2):204-11</RefSource>                <PMID Version="1">15669929</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Endocrinol Metab. 2017 Oct 1;102(10):3647-3661</RefSource>                <PMID Version="1">28934376</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Obstet Gynecol. 2003 Feb;101(2):337-45</RefSource>                <PMID Version="1">12576259</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Menopause. 2015 Nov;22(11):1155-72; quiz 1173-4</RefSource>                <PMID Version="1">26382310</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Oncol. 2016;55(2):188-92</RefSource>                <PMID Version="1">26243443</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Gen Pract. 2013 Jan;63(606):51-2</RefSource>                <PMID Version="1">23336472</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2011 Jul;19(7):941-7</RefSource>                <PMID Version="1">20496155</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Steroid Biochem Mol Biol. 2016 May;159:142-53</RefSource>                <PMID Version="1">26972555</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2016 Nov;160(2):223-236</RefSource>                <PMID Version="1">27709351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mayo Clin Proc. 2016 Aug;91(8):1133-46</RefSource>                <PMID Version="1">27492917</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000588" MajorTopicYN="N">Amines</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003509" MajorTopicYN="N">Cyclohexanecarboxylic Acids</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008019" MajorTopicYN="Y">Life Style</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008593" MajorTopicYN="Y">Menopause</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005680" MajorTopicYN="N">gamma-Aminobutyric Acid</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30073604</ArticleId>            <ArticleId IdType="doi">10.1007/s40266-018-0574-y</ArticleId>            <ArticleId IdType="pii">10.1007/s40266-018-0574-y</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>